According to the CDC, Clostridium difficile is now the most common microbial healthcare associated infection (HAI), with annual healthcare costs exceeding $4.8 billion. Approximately 15,000 deaths are attributable to C. difficile infection each year in the US.
Clostridium difficile infections cause symptoms that range from mild diarrhea to the more severe and potentially fatal pseudomembranous colitis
The value of VERIGENE® Clostridium difficile Test (CDF)
Empower clinicians to rapidly and accurately diagnose C. difficile to ensure appropriate treatment
Proven clinical impact
Rapid identification of C. difficile can help ensure appropriate patient treatment and improve infection control protocols.
Outstanding economic value
Decrease costs by improved infection control measures that reduce the length of stay.
The VERIGENE® System provides an easy-to-use C. difficile test that delivers accurate test results in < 2 hours.
How the VERIGENE® Clostridium difficile Test works
VERIGENE® Clostridium difficile is a multiplexed, qualitative test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic C. difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens.
Consumables arrive at the laboratory ready to use with no further reagent preparation.
Faster time to results
By simultaneously targeting both the toxin A and toxin B genes and differentiating the 027 strain, VERIGENE® Clostridium difficile Test delivers comprehensive results directly from a stool sample in less than 2 hours.
VERIGENE® Clostridium difficile Kit
The VERIGENE® C. difficile (CDF) Test is a rapid, easy-to-use, and cost-effective in vitro diagnostic test for the rapid dection of C. difficile that delivers clinical, economic, and workflow benefits to hospitals and laboratories.
Toxin A (tcdA gene)
Toxin B (tcdB gene)
PCR Ribotype 027 hypervirulent strain*
For use with the VERIGENE® System
The VERIGENE® System rapidly and accurately detects infectious pathogens. Delivery of this time-critical information allows clinicians to provide targeted patient care more quickly, potentially leading to improved patient outcomes and lower treatment costs. VERIGENE®’s ease of use makes it a valuable system for use in both hospital-based and reference laboratories.
VERIGENE® Clostridium difficile Test Ordering info
VERIGENE® Clostridium difficile Nucleic Acid Test (CDF) Kit
VERIGENE® Clostridium difficile Nucleic Acid Test (CDF) Amplification Reagent Kit
20 CDF Amplification Trays